Ind-Swift Laboratories Limited (ISLL) has provided a clarification to the National Stock Exchange of India (NSE) regarding a recent increase in the volume and price of its shares. In response to an email dated April 8, 2026, the company stated that it has consistently disclosed all material information impacting its operations and performance in accordance with SEBI regulations. The company is not aware of any specific reason for the sudden spurt in its shares, attributing it to market-driven factors. However, ISLL highlighted its recent disclosure on April 7, 2026, concerning the receipt of an Arbitration Award as a potential contributing factor. Separately, on April 7, 2026, Ind-Swift Laboratories informed both the BSE and NSE about the final order passed by the Arbitral Tribunal in the arbitration proceedings with M/s. PI Industries Limited. The Arbitral Tribunal, constituted by the Mumbai Centre for International Arbitration (MCIA), rejected all claims made by PI Industries Limited as well as all counterclaims by Ind-Swift Laboratories Limited and others. Consequently, the arbitration proceedings have concluded with no financial impact on the company. This final award was received on April 7, 2026, and the proceedings are now concluded.
